Dr. Milani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
23600 Telo Ave
#260
Torrance, CA 90505Phone+1 424-435-1037
Education & Training
- Brown UniversityFellowship, Hematology and Medical Oncology, 2007 - 2010
- Roger Williams Medical CenterResidency, Internal Medicine, 2004 - 2007
Certifications & Licensure
- CA State Medical License 2008 - 2026
- ID State Medical License 2024 - 2025
- OR State Medical License 2024 - 2025
- NM State Medical License 2023 - 2024
- RI State Medical License 2005 - 2010
- DC State Medical License 2005 - 2006
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
Publications & Presentations
PubMed
- 130 citationsClinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma.Jorge J. Castillo, Eric S. Winer, Dariusz Stachurski, Kimberly Perez, Melhem Jabbour
Leukemia & Lymphoma. 2010-11-15 - 94 citationsPrognostic Factors in Chemotherapy-Treated Patients with HIV-Associated Plasmablastic LymphomaJorge J. Castillo, Eric S. Winer, Dariusz Stachurski, Kimberly Perez, Melhem Jabbour
The Oncologist. 2010-03-01 - 50 citationsOfatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disordersJorge J. Castillo, Cannon Milani, Daniel Mendez-Allwood
Expert Opinion on Investigational Drugs. 2009-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: